B+L's Once-Daily Prolensa Approved for Post-Cataract Care

May 2013
Review of Ophthalmology;May2013, Vol. 20 Issue 5, p6
Trade Publication
The article informs that the U.S. Food and Drug Administration has approved the company Bausch + Lomb's New Drug Application for Prolensa 0.07 percent prescription eye drop for the treatment of inflammation and ocular pain after cataract surgery.


Related Articles

  • FDA grants Besivance 0.6% additional indications.  // Optometry Times;Oct2012, Vol. 4 Issue 10, p10 

    The article offers information on the additional labelling indications granted by the U.S. Food and Drugs Administration for Bausch + Lomb's Besivance or besifloxacin ophthalmic suspension 0.6 percent eye drop.

  • Bausch + Lomb Stresses Innovation.  // MMR;9/15/2014, Vol. 31 Issue 15, p14 

    The article offers brief information on several eye care products from Bausch + Lomb such as the Soothe Xtra Protection eye drops and the Peroxi-Clear 3% hydrogen cleaning and disinfectant solution for contact lenses.

  • IOL injector technology aims to keep pace with microincisional phaco platforms. Hasson, Matt // Ocular Surgery News Europe/Asia-Pacific Edition;Sep2008, Vol. 19 Issue 9, p28 

    The article discusses trends in intraocular lens (IOL) injection systems that aim to make cataract surgery safer, faster and more sterile. Commercial IOL injection systems mentioned include the Unfolder Series from Advanced Medical Optics, SofPort Advanced Optics Lens Insertion System with...

  • B&L launches microsurgical system.  // Ophthalmology Times;11/1/2007, Vol. 32 Issue 21, p6 

    The article presents information on the launch of Stellaris Vision Enhancement System, a microsurgical system for cataract by Bausch & Lomb Inc. According to the company, the system is appropriate for all techniques, particularly 1.8-mm biaxial and 1 .8-mm coaxial procedures. According to...

  • Research & Markets: IMS Company Profiles: Bausch & Lomb Features R&D Pipelines, Analysts Forecasts and Events Predicted To Impact the Future.  // Biomedical Market Newsletter;5/14/2011, p664 

    The article reports that Research & Markets Ltd. has added, IMS Company Profiles: Bausch & Lomb Inc., to their profile, which explains the company's strength in terms of therapy areas and relevant marketed products.

  • Vitamins and eye drops.  // Optometry Today;9/30/2011, Vol. 51 Issue 19, p42 

    The article offers descriptions of vitamins and eye drops for the eyes including Artelac Splash from Bausch & Lomb, Systane Gel Drops Lubricant Eye Gel from Alcon, and Viteyes II nutritional supplement from Butterfiles Healthcare.

  • Product Review.  // Review of Optometry;10/15/2012, Vol. 149 Issue 10, p110 

    The article reviews several products for optometry which includes Lotemox Gel Drop from Bausch & Lomb Inc., pedestal case from Tecno Display Inc. and spectacles frames from Daine von Furstenberg.

  • Launches galore... Moss, Robina // Optometry Today;6/28/2013, Vol. 53 Issue 13, p18 

    The article previews several products, including the MyDay daily disposable contact lens with Smart Silicone chemistry from CooperVision, the PureVision2 for Presbypia monthly silicone hydrogel multifocal contact lenses from Bausch & Lomb, and the preservative-free Hyabak dry eye treatment from...

  • Treating dry eye with lipid-based eye drops. FOGT, JENNIFER; BARR, JOSEPH T. // Optometry Times;Sep2015, Vol. 7 Issue 9, p26 

    The article discusses use of lipid-containing eye drops for monitoring the changes in lipid layer of the tear film while treating dry eye. It lists various drops that are available in the market including Soothe XP from Bausch + Lomb, Systane Balance from Alcon and Refresh Optive Advanced from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics